Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
47,607,776
-
Share change
-
+225,142
-
Total reported value
-
$18,402,998
-
Put/Call ratio
-
0%
-
Price per share
-
$0.39
-
Number of holders
-
55
-
Value change
-
-$82,394
-
Number of buys
-
22
-
Number of sells
-
26
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q3 2022
As of 30 Sep 2022,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,607,776 shares.
The largest 10 holders included
NEA Management Company, LLC, VANGUARD GROUP INC, Anson Funds Management LP, BVF INC/IL, ACADIAN ASSET MANAGEMENT LLC, BOXER CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, Laurion Capital Management LP, DAFNA Capital Management LLC, and BlackRock Inc..
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.